UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC

Journal of thoracic oncology, 2021-12, Vol.16 (12), p.2078-2090

2021

Volltextzugriff (PDF)

Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer

Japanese journal of clinical oncology, 2022-04, Vol.52 (4), p.383-387

2022

Volltextzugriff (PDF)

Lung Cancer in Japan

Journal of thoracic oncology, 2022-03, Vol.17 (3), p.353-361

2022

Volltextzugriff (PDF)

Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan

World journal of surgery, 2016-05, Vol.40 (5), p.1165-1171

2016

Volltextzugriff (PDF)

A school‐aged case of intratumor bleeding of an adrenal neuroblastoma rescued by transcatheter atrial embolization

Pediatrics international, 2022-01, Vol.64 (1), p.e14987-n/a

2022

Volltextzugriff (PDF)

Estimating the insertion length of pediatric peripherally inserted central catheters

Pediatrics international, 2022-01, Vol.64 (1), p.e15128-n/a

2022

Volltextzugriff (PDF)

Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world

Journal of cancer research and clinical oncology, 2022-07, Vol.148 (7), p.1737-1746

2022

Volltextzugriff (PDF)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy

Cancer science, 2023-02, Vol.114 (2), p.630-639

2023

Volltextzugriff (PDF)

Differential immune-related microenvironment determines PD-1/PD-L1 blockade efficacy in advanced non-small cell lung cancer patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9044-9044

2021

Volltextzugriff (PDF)

Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer

Clinical lung cancer, 2015-09, Vol.16 (5), p.385-390

2015

Volltextzugriff (PDF)

Position-dependent and neuron-specific splicing regulation by the CELF family RNA-binding protein UNC-75 in Caenorhabditis elegans

Nucleic acids research, 2013-04, Vol.41 (7), p.4015

2013

Volltextzugriff (PDF)

Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world

Journal of cancer research and clinical oncology, 2022-07, Vol.148 (7), p.1747-1747

2022

Volltextzugriff (PDF)

MO2-4 Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in older adults aged over 75 years

Annals of oncology, 2023-11, Vol.34, p.S1395-S1395

2023

Volltextzugriff (PDF)

Development and validation of a prediction model for the recurrence of stage 1 EGFR mutation positive NSCLC in patients using machine learning with WES-based gene sets

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8563-8563

2023

Volltextzugriff (PDF)

Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in adults aged older than 75 years

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21098-e21098

2023

Volltextzugriff (PDF)

Tumor microenvironment-mediated immune profiles and efficacy of platinum doublet chemotherapy plus ICIs stratified by DLL3 expression in small cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8586-8586

2023

Volltextzugriff (PDF)

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients

British journal of ophthalmology, 2012-10, Vol.96 (10), p.1310-1315

2012

Volltextzugriff (PDF)

MO16-3 Results of the first survey using EORTC QLQ INFO25 on information acquisition and satisfaction of lung cancer patients

Annals of oncology, 2021-07, Vol.32, p.S306-S306

2021

Volltextzugriff (PDF)

High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group)

Japanese journal of clinical oncology, 2024-08

2024

Volltextzugriff (PDF)

Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older

Clinical pharmacology and therapeutics, 2024-06

2024

Volltextzugriff (PDF)

MO1-1 LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab + ipilimumab +/- chemotherapy for NSCLC in Japan

Annals of oncology, 2023-11, Vol.34, p.S1393-S1393

2023

Volltextzugriff (PDF)

Impact of chemoradiotherapy (CRT) on immune-related tumor microenvironment and the efficacy of anti-PD-1 therapy after the recurrence of CRT in unresectable locally advanced NSCLC patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21719-e21719

2020

Volltextzugriff (PDF)

Comparison of radiotherapy and chemoradiotherapy for locoregional recurrence of non-small cell lung cancer developing after surgery

Clinical lung cancer, 2017-11, Vol.18 (6), p.e441-e448

2017

Volltextzugriff (PDF)

Management of Right Gastroepiploic Arterial Coronary Grafts in Subsequent Abdominal Surgeries

The Annals of thoracic surgery, 2018-07, Vol.106 (1), p.52-57

2018

Volltextzugriff (PDF)

First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study

Japanese journal of clinical oncology, 2024-04, Vol.54 (4), p.452-462

2024

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(23)
Oncology
(13)
Male
(11)
Retrospective Studies
(11)
Female
(10)
Aged
(8)
Adult
(7)
Lung Neoplasms - Drug Therapy
(7)
Lung Neoplasms - Pathology
(6)
Middle Aged
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Original
(5)
Respiratory System
(5)
Surgery
(5)
Cancer Therapies
(4)
Chemotherapy
(4)
Lung Cancer
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC

Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer

Lung Cancer in Japan

Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan

A school‐aged case of intratumor bleeding of an adrenal neuroblastoma rescued by transcatheter atrial embolization

Estimating the insertion length of pediatric peripherally inserted central catheters

Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy

Differential immune-related microenvironment determines PD-1/PD-L1 blockade efficacy in advanced non-small cell lung cancer patients

Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer

Position-dependent and neuron-specific splicing regulation by the CELF family RNA-binding protein UNC-75 in Caenorhabditis elegans

Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world

MO2-4 Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in older adults aged over 75 years

Development and validation of a prediction model for the recurrence of stage 1 EGFR mutation positive NSCLC in patients using machine learning with WES-based gene sets

Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in adults aged older than 75 years

Tumor microenvironment-mediated immune profiles and efficacy of platinum doublet chemotherapy plus ICIs stratified by DLL3 expression in small cell lung cancer

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients

MO16-3 Results of the first survey using EORTC QLQ INFO25 on information acquisition and satisfaction of lung cancer patients

High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group)

Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older

MO1-1 LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab + ipilimumab +/- chemotherapy for NSCLC in Japan

Impact of chemoradiotherapy (CRT) on immune-related tumor microenvironment and the efficacy of anti-PD-1 therapy after the recurrence of CRT in unresectable locally advanced NSCLC patients

Comparison of radiotherapy and chemoradiotherapy for locoregional recurrence of non-small cell lung cancer developing after surgery

Management of Right Gastroepiploic Arterial Coronary Grafts in Subsequent Abdominal Surgeries

First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study

Aktive Filter

Suchergebnisse filtern